Literature DB >> 12030716

Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.

A Günther1, R Schmidt, J Harodt, T Schmehl, D Walmrath, C Ruppert, F Grimminger, W Seeger.   

Abstract

The purpose of the present study was to investigate the impact of bronchoscopic surfactant administration, on the biochemical and biophysical surfactant properties, in patients with severe and early acute respiratory distress syndrome (ARDS) and septic shock. A total number of 27 ARDS patients received 300-500 mg x kg x body x weight(-1) of a natural bovine surfactant extract (Alveofact) via a flexible bronchoscope. Bronchoalveolar lavages were performed 3 h prior to, and 15-18 h and 72 h after surfactant administration. A comparison to healthy volunteers, undergoing an identical lavage procedure, was made (control, n=12). Severe biophysical and biochemical surfactant abnormalities were encountered throughout in the ARDS patients. These included a massive alveolar protein load, a reduced percentage of large surfactant aggregates (LA), a loss of palmitoylated phosphatidylcholine species and a significant reduction of surfactant apoprotein (SP)-A, SP-B and SP-C in the LA fraction. Both minimum (gammamin) and adsorption (gammaads) surface tension values (pulsating bubble surfactometer) were dramatically increased. Surfactant treatment resulted in a marked increase in the lavagable phospholipid (PL) pool, but predominance of the alveolar surfactant-inhibitory protein load was still encountered. Far-reaching or even complete normalization of the PL profile, the LA fraction and its SP-B and SP-C (but not SP-A) content as well as the fatty acid composition of the phosphatidylcholine class was noted. Surface tension lowering properties (gammamin and gammaads) significantly improved, but were still not fully normalized. Bronchoscopic administration of large quantities of natural bovine surfactant in severe acute respiratory distress syndrome causes far-reaching restoration of biochemical surfactant properties and significant improvement, however not full normalization, of biophysical surfactant function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030716     DOI: 10.1183/09031936.02.00243302

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  Protective effects of dexamethasone on early acute lung injury induced by oleic acid in rats.

Authors:  Bin Huang; Dao-Xin Wang; Wang Deng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.

Authors:  Joseph A Zasadzinski; T F Alig; Coralie Alonso; Jorge Bernardino de la Serna; Jesus Perez-Gil; H William Taeusch
Journal:  Biophys J       Date:  2005-07-08       Impact factor: 4.033

Review 3.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

4.  Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Authors:  Philipp Markart; Clemens Ruppert; Malgorzata Wygrecka; Thorsten Colaris; Bhola Dahal; Dieter Walmrath; Heinz Harbach; Jochen Wilhelm; Werner Seeger; Reinhold Schmidt; Andreas Guenther
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

Review 5.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 6.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

Review 7.  Acute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implication.

Authors:  Chain-Fa Su; Shang Jyh Kao; Hsing I Chen
Journal:  World J Crit Care Med       Date:  2012-04-04

8.  A novel and stable "two-hit" acute lung injury model induced by oleic acid in piglets.

Authors:  Xiaofeng Li; Yinglong Liu; Qiang Wang; Yaobin Zhu; Xiaodong Lv; Jinping Liu
Journal:  Acta Vet Scand       Date:  2009-03-30       Impact factor: 1.695

Review 9.  Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?

Authors:  Ahilanandan Dushianthan; Rebecca Cusack; Victoria Goss; Anthony D Postle; Mike P W Grocott
Journal:  Crit Care       Date:  2012-11-22       Impact factor: 9.097

10.  Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.

Authors:  Roberta L Keller; Jeffrey D Merrill; Dennis M Black; Robin H Steinhorn; Eric C Eichenwald; David J Durand; Rita M Ryan; William E Truog; Sherry E Courtney; Philip L Ballard; Roberta A Ballard
Journal:  Pediatr Res       Date:  2012-10-04       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.